Infection with respiratory syncytial virus and water-soluble components of cigarette smoke alter production of tumour necrosis factor α and nitric oxide by human blood monocytes
Open Access
- 1 July 1999
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 24 (4) , 387-394
Abstract
Cigarette smoke and virus infections contribute to the pathogenesis and exacerbation of chronic obstructive pulmonary disease and asthma. The objective of this study was to examine the effects of a water-soluble cigarette smoke extract (CSE) and/or respiratory syncytial virus (RSV) infection on release from monocytes of the blood from donors of tumour necrosis factor a (α) and nitric oxide (NO). Both RSV infection and CSE stimulated α release from monocytes and there was an additive effect if both the agents were present. There was a decrease in NO release, but the effect was significant only with CSE or a combination of CSE and RSV infection. Interferon γ significantly increased α release and cotinine significantly increased NO release. Nicotine decreased both α and NO responses. The general pattern observed for individual donors was increased α and decreased NO. The proportion of extreme responses with very high α and very low NO in the presence of both RSV and CSE increased to 20% compared with 5% observed with CSE or RSV alone. The results show that RSV infection and components of cigarette smoke elicit inflammatory responses that could contribute to damage to the respiratory tract and these individual factors could be more harmful in combination.Keywords
This publication has 27 references indexed in Scilit:
- Developmental and environmental factors that enhance binding ofBordetella pertussisto human epithelial cells in relation to sudden infant death syndrome (SIDS)FEMS Immunology & Medical Microbiology, 1996
- Effects of Nicotine on the Immune Response. I. Chronic Exposure to Nicotine Impairs Antigen Receptor-Mediated Signal Transduction in LymphocytesToxicology and Applied Pharmacology, 1995
- Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity.Journal of Clinical Investigation, 1995
- The Role of Nitric Oxide in the Pathogenesis of Virus-Induced Encephalopathies1995
- Interaction of alveolar macrophages and respiratory syncytial virusJournal of Immunological Methods, 1994
- Nitric oxide and lung disease.Thorax, 1993
- Restricted replication of respiratory syncytial virus in human alveolar macrophagesJournal of General Virology, 1993
- Effect of respiratory syncytial virus infection on binding ofNeisseria meningitidisandHaemophilus influenzaetype b to a human epithelial cell line (HEp-2)Epidemiology and Infection, 1993
- Inhibition of Mouse Alveolar Macrophage Production of Tumor Necrosis Factor Alpha by Acute in vivo and in vitro Exposure to Tobacco SmokeRespiration, 1992
- Immunity to and Frequency of Reinfection with Respiratory Syncytial VirusThe Journal of Infectious Diseases, 1991